劲方医药-B(02595)

30.700-0.300-0.97%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
劲方医药-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.genfleet.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
劲方医药科技（上海）有限公司是一家专注于创新药物研发的中国公司。该公司为肿瘤、自身免疫性疾病和炎症性疾病提供有效的新型治疗方案。该公司的研发平台涵盖靶点发现、分子发现与评估、转化科学和临床开发，以及制剂研究、工艺开发和质量分析等关键化学生产和控制环节。该公司主要致力于新分子类型和新药物模式的开发，分子工艺路线和质量标准的研究，以及差异化临床开发策略和路径的探索。该公司主要在中国国内和海外市场开展业务。
- 01-23
  股份购回
  (1) 建议采纳H股购股权计划(2) 建议采纳H股股份激励计划(3) 建议授权董事会及╱ 或授权人士处理与股份计划有关的事宜(4) 建议授出一般授权以购回H股(5) 建议取消监事会及修订组织章程细则及(6) 股东特别大会通告
  (1) 建议采纳H股购股权计划(2) 建议采纳H股股份激励计划(3) 建议授权董事会及╱ 或授权人士处理与股份计划有关的事宜(4) 建议授出一般授权以购回H股(5) 建议取消监事会及修订组织章程细则及(6) 股东特别大会通告
- 2025-09-30
  半年度报告
  2025 年中期报告
  2025 年中期报告
- 2025-09-11
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

数据加载中...

最高

32.460

今开

31.500

量比

1.08

最低

29.300

昨收

31.000

换手率

0.24%

热议股票

{"pagemeta":{"title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"劲方医药-B,02595,劲方医药-B股票,劲方医药-B股票老虎,劲方医药-B股票老虎国际,劲方医药-B行情,劲方医药-B股票行情,劲方医药-B股价,劲方医药-B股市,劲方医药-B股票价格,劲方医药-B股票交易,劲方医药-B股票购买,劲方医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"02595","data":{"stockData":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"劲方医药-B","latestPrice":30.7,"timestamp":1769760482451,"preClose":31,"halted":0,"volume":796200,"delay":0,"changeRate":-0.009677419354838733,"floatShares":338000000,"shares":370000000,"eps":-26.20482,"marketStatus":"已收盘","change":-0.3,"latestTime":"01-30 16:08:02","open":31.5,"high":32.46,"low":29.3,"amount":24557382,"amplitude":0.101935,"askPrice":30.7,"askSize":5000,"bidPrice":30.3,"bidSize":17400,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":31,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":1.075383,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20654958","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGuh7USd45n","pdf_url":"https://static.tigerbbs.com/ef9e09e90a4d4a73b187a7d9d4f6e5ac","pub_time":1769124600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1) 建议采纳H股购股权计划(2) 建议采纳H股股份激励计划(3) 建议授权董事会及╱ 或授权人士处理与股份计划有关的事宜(4) 建议授出一般授权以购回H股(5) 建议取消监事会及修订组织章程细则及(6) 股东特别大会通告","symbol":"02595","title":"(1) 建议采纳H股购股权计划(2) 建议采纳H股股份激励计划(3) 建议授权董事会及╱ 或授权人士处理与股份计划有关的事宜(4) 建议授出一般授权以购回H股(5) 建议取消监事会及修订组织章程细则及(6) 股东特别大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0123/2026012300090_c.pdf","us_notice_code":"通函 - [股份计划 / 修订宪章文件 / 一般性授权 / 回购股份的说明函件 / 其他]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-01-23 07:30","pubTimestamp":1769124600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20226430","market":"hk","labels":[],"media":"港交所","original_id":"N.HK1296vt2oJR","pdf_url":"https://static.tigerbbs.com/3cf0c09b40634ea78c61dabc6cb2cc99","pub_time":1759228920000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025 年中期报告","symbol":"02595","title":"2025 年中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0930/2025093002145_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-30 18:42","pubTimestamp":1759228920,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20154077","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGx9aP2VgkQ","pdf_url":"https://static.tigerbbs.com/f576fbc4aa2b44239e7d36485acbf7f1","pub_time":1757545140000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"02595","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0911/2025091100032_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2025-09-11 06:59","pubTimestamp":1757545140,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.genfleet.com","stockEarnings":[{"period":"1week","weight":0.1355},{"period":"1month","weight":0.342},{"period":"3month","weight":0.1347},{"period":"6month","weight":0.5204},{"period":"ytd","weight":0.3036}],"compareEarnings":[{"period":"1week","weight":0.0502},{"period":"1month","weight":0.0817},{"period":"3month","weight":0.0796},{"period":"6month","weight":0.1412},{"period":"1year","weight":0.3828},{"period":"ytd","weight":0.0912}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"劲方医药科技（上海）有限公司是一家专注于创新药物研发的中国公司。该公司为肿瘤、自身免疫性疾病和炎症性疾病提供有效的新型治疗方案。该公司的研发平台涵盖靶点发现、分子发现与评估、转化科学和临床开发，以及制剂研究、工艺开发和质量分析等关键化学生产和控制环节。该公司主要致力于新分子类型和新药物模式的开发，分子工艺路线和质量标准的研究，以及差异化临床开发策略和路径的探索。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"劲方医药-B","nameEN":"GENFLEET-B"},"aProfile":null}}}